logo
Select company
Select metric
$ -72.71MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
14
Sector
11
Industry
11
History
12
$ 7.75Close
$ 4.63 - $ 8.89 52-Week Range
Ticker Information

Ticker

MGTX

Company Name

MEIRAGTX HOLDINGS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEIRAGTX HOLDINGS PLC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGTX - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -72.71M
3/31/2025$ -52.64M
12/31/2024$ -26.48M
9/30/2024$ 58.11M
6/30/2024$ 6.11M
3/31/2024$ 49.25M
12/31/2023$ 12.69M
9/30/2023$ -51.58M
6/30/2023$ 19.02M
3/31/2023$ -46.75M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEIRAGTX HOLDINGS PLC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -74.54M.
  • Over the past 5 years, MEIRAGTX HOLDINGS PLC's average CF - Chg. Cash has been $ -28.64M.
  • The median CF - Chg. Cash for MEIRAGTX HOLDINGS PLC during this period was $ -27.33M
  • MEIRAGTX HOLDINGS PLC reached its highest CF - Chg. Cash over the past 5 years at $ 58.11M.
  • The lowest CF - Chg. Cash recorded by MEIRAGTX HOLDINGS PLC in the same timeframe $ -99.43M

MEIRAGTX HOLDINGS PLC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
GOSS : GOSSAMER BIO INC $ -60.57MAUTL : AUTOLUS THERAPEUTICS PLC $ -581.63MEYPT : EYEPOINT PHARMACEUTICALS INC $ -19.63MTNGX : TANGO THERAPEUTICS INC $ -12.29MVIR : VIR BIOTECHNOLOGY INC $ -10.9MABUS : ARBUTUS BIOPHARMA CORP $ -25.38MZBIO : ZENAS BIOPHARMA INC $ -140.01MXOMA : XOMA ROYALTY CORP $ -71.44MZVRA : ZEVRA THERAPEUTICS INC $ 8.45MBCYC : BICYCLE THERAPEUTICS PLC $ -239.91M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

MGTX - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -99.43M

Minimum

Jun 30, 2022

$ 58.11M

Maximum

Sep 30, 2024

$ -28.64M

Average

$ -27.33M

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M